Potential impact of parental Tdap immunization on infant pertussis hospitalizations

Vaccine

Volumn 30, Issue 37, 2012, Pages 5527-5532

  Peters, Timothy R ^a   Banks, Gretchen C ^a   Snively, Beverly M ^a   Poehling, Katherine A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bordetella pertussis; Cocooning; Parental immunization; Tdap

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; CHILD HOSPITALIZATION; DRUG EFFICACY; HUMAN; IMMUNIZATION; INFANT; INFANT DISEASE; PERTUSSIS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; UNITED STATES;

DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALE; PARENTS; POSTPARTUM PERIOD; PREGNANCY; PROGRAM EVALUATION; UNITED STATES; WHOOPING COUGH;

EID: 84864317074     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.047     Document Type: Article

References (36)

1. Tanaka M., Vitek C.R., Pascual F.B., Bisgard K.M., Tate J.E., Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003, 290:2968-2975.
2. Cortese M.M., Baughman A.L., Zhang R., Srivastava P.U., Wallace G.S. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics 2008, 121:484-492.
3. Hanson M.P., Kwan-Gett T.S., Baer A., Rietberg K., Ohrt M., Duchin J.S. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: king county, washington, 2002 through 2007. Arch Pediatr Adolesc Med 2011, 165:647-652.
4. Falcon M., Rafael M., Garcia C., Fergie J., Purcell K. Increasing infant pertussis hospitalization and mortality in South Texas, 1996 to 2006. Pediatr Infect Dis J 2010, 29:265-267.
5. O'Brien J.A., Caro J.J. Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis 2005, 5:57.
6. Bisgard K.M., Pascual F.B., Ehresmann K.R., Miller C.A., Cianfrini C., Jennings C.E., et al. Infant pertussis: who was the source?. Pediatr Infect Dis J 2004, 23:985-989.
7. Kowalzik F., Barbosa A.P., Fernandes V.R., Carvalho P.R., Avila-Aguero M.L., Goh D.Y., et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007, 26:238-242.
8. Cortese M.M., Baughman A.L., Brown K., Srivastava P. A " new age" in pertussis prevention new opportunities through adult vaccination. Am J Prev Med 2007, 32:177-185.
9. Walter E.B., Allred N., Rowe-West B., Chmielewski K., Kretsinger K., Dolor R.J. Cocooning infants: Tdap immunization for new parents in the pediatric office. Acad Pediatr 2009, 9:344-347.
10. Westra T.A., de V.R., Tamminga J.J., Sauboin C.J., Postma M.J. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther 2010, 32:1479-1495.
11. Durand C., Flament E. Pertussis vaccination for parents: proposal and evaluation of two professional practices in a maternity hospital. Arch Pediatr 2011, 18:362-369.
12. Healy C.M., Rench M.A., Baker C.J. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 2011, 52:157-162.
13. Broder K.R., Cortese M.M., Iskander J.K., Kretsinger K., Slade B.A., Brown K.H., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55:1-34.
14. Kretsinger K., Broder K.R., Cortese M.M., Joyce M.P., Ortega-Sanchez I., Lee G.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006, 55:1-37.
15. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011, 60:1424-1426.
16. Adult vaccination coverage - United States, 2010. MMWR 2012, 61:66-72.
17. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011, 204:334-335.
18. Trick W.E., Linn E.S., Jones Z., Caquelin C., Kee R., Morita J.Y. Using computer decision support to increase maternal postpartum tetanus, diphtheria, and acellular pertussis vaccination. Obstet Gynecol 2010, 116:51-57.
19. Carmenga D.R., Kyanko K., Stepczynski J., Flaherty-Hewitt M., Curry L., Sewell D., et al. Increasing adult Tdap vaccination rates by vaccinating infant caregivers in the pediatric office. Acad Pediatr 2012, 12:20-25.
20. Murphy T.V., Syed S.B., Holman R.C., Haberling D.L., Singleton R.J., Steiner C.A., et al. Pertussis-associated hospitalizations in American Indian and Alaska Native infants. J Pediatr 2008, 152:839-843.
21. Crespo I., Cardeñosa N., Godoy P., Carmona G., Sala M.R., Barrabeig I., et al. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine 2011, 29:4244-4248.
22. Bonmarin I., Levy-Bruhl D., Baron S., Guiso N., Njamkepo E., Caro V. Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill 2007, 12.
23. Wall R., Bell A., Theobald J. Pertussis (whooping cough) epidemiology in Waikato, New Zealand: 2000-2009. N Z Med J 2011, 124:52-61.
24. Wood N., Quinn H.E., McIntyre P., Elliott E. Pertussis in infants: preventing deaths and hospitalisations in the very young. J Paediatr Child Health 2008, 44:161-165.
25. Skowronski D.M., Janjua N.Z., Tsafack E.P., Ouakki M., Hoang L., De S.G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012, 54:318-327.
26. de Greeff S.C., Mooi F.R., Westerhof A., Verbakel J.M., Peeters M.F., Heuvelman C.J., et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010, 50:1339-1345.
27. Wendelboe A.M., Njamkepo E., Bourillon A., Floret D.D., Gaudelus J., Gerber M., et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007, 26:293-299.
28. Chuk L.M., Lambert S.B., May M.L., Beard F.H., Sloots T.P., Selvey C.E., et al. Pertussis in infants: how to protect the vulnerable?. Commun Dis Intell 2008, 32:449-456.
29. Ward J.I., Cherry J.D., Chang S.J., Partridge S., Lee H., Treanor J., et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005, 353:1555-1563.
30. Rank C., Quinn H.E., McIntyre P.B. Pertussis vaccine effectiveness after mass immunization of high school students in Australia. Pediatr Infect Dis J 2009, 28:152-153.
31. Cherry J.D. Why do pertussis vaccines fail?. Pediatrics 2012, 129:968-970.
32. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Mathews T.J., Kirmeyer S., et al. Births: final data for 2007. Natl Vital Stat Rep 2010, 58:1-85.
33. Tomovici A., Barreto L., Zickler P., Meekison W., Noya F., Voloshen T., et al. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine 2012, 30:2647-2653.
34. Dorell C., Stokley S., Yankey D., Cohn A., Markowitz L. National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States 2009. MMWR 2010, 59:1018-1023.
35. Miller B.L., Ahmed F., Lu P.J., Euler G.L. Tetanus and pertussis vaccination coverage among adults aged ≥18 years - United States, 1999 and 2008. MMWR 2010, 59:1302-1306.
36. Recommended adult immunization schedule: United States, 2012. Ann Intern Med 2012, 156:211-217.